Women not attending cervical screening programs are at increased risk of cervical cancer.
We investigated in these nonresponders to what extent offering self‐sampling devices for …

… Human papillomavirus testing with ST management resulted … Scale-up of a low-cost
human papillomavirus testing … Human papillomavirus (HPV) tests used for cervical cancer …

Even in the era of highly effective human papillomavirus (HPV) prophylactic vaccines,
substantial reduction in worldwide cervical cancer mortality will only be realized if effective early …

With more than 200 types identified, human papillomavirus (HPV) commonly causes infections
of the skin and mucosa. HPV infection is the most common sexually transmitted infection …

… Human papillomavirus testing 2007–2012: Co-testing and … -risk human papillomavirus (HPV)
testing is recommended for … (ASC-US) cytology, and co-testing with cytology and HPV is a …

… Results at recruitment from a randomized controlled trial comparing human papillomavirus
testing alone with conventional cytology as the primary cervical cancer screening test.  …

While its prognostic significance remains unclear, p16 INK4a protein expression is increasingly
being used as a surrogate marker for oncogenic human papillomavirus (HPV) infection …

… -collected human papillomavirus (HPV) testing for … testing to standard clinician-collected
Pap screening. Participants were surveyed about their attitudes toward self-collected HPV testing…

Context.— The most recent update to cervical cancer screening guidelines offers interim
guidance on the use of primary human papillomavirus (HPV) screening, with algorithms for …

Background: Some countries have implemented stand-alone human papillomavirus (HPV)
testing while others consider cotesting for cervical cancer screening. We compared both …